Navigation Links
Video: Food Expert B. Smith to Provide Healthy Menu Makeovers
Date:10/10/2007

effect on managing diabetes successfully. The campaign is also an important component of Merck's Journey for Control program which supports patients, educators, health care providers and health plans in advancing care and self-management of type 2 diabetes.

About Diabetes

According to the American Diabetes Association, diabetes is the fifth leading cause of death by disease in the United States and costs approximately $132 billion per year in direct and indirect medical expenses. Patients with diabetes can develop heart disease, kidney disease, blindness, vascular or neurological problems that can lead to amputation and can suffer increased rates of mortality. There are currently more than 230 million people with diabetes worldwide, and if nothing is done to slow the epidemic, the worldwide number may exceed 350 million by 2025.

About AACE

AACE is a professional medical organization with more than 6,000 members in the United States and 84 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine disease, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.

About Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. Fo
'/>"/>

SOURCE Merck & Co., Inc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Smoking a greater risk than HIV? Yes say health experts!!!!
2. Roche offers HIV drug expertise to poor nations
3. Good carb, bad carb? Experts debate.
4. Serevent, to be examined by experts due to deaths associated with its use
5. Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts
6. Experts Recommend Preventive Measures For Avian Flu To Begin From Farms
7. Experts Insist That Neonatal Herpes Be Reported Regularly
8. Experts State Strategies To Increase Good Cholesterol
9. Speed up bird flu vaccine, Bush tells experts
10. Tennis elbow not new among cricketers, say experts
11. Weight-Loss Medication Evaluated By Nutrition Expert
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ad to a novel technique to combat cancer, study sa...ws) -- Belgian researchers have discovered that so...or food, and this might lead to new treatments tha... proliferate, all cells in the body need to produc... a process that requires oxygen. Compared with nor...
(Date:11/21/2008)...d To Vigorously Protect Investment And Restore Sha...ewswire-USNewswire/ -- Dr. Stephen Joffe, Craig Jo...heir Schedule 13D with the U.S. Securities and Exc...D disclosing ownership of 11.4% of LCA-Vision, Inc...ixed-site laser vision correction centers in 33 st...
(Date:11/21/2008)... Barr Pharmaceuticals, In...lders overwhelmingly approved the proposals submit... Teva Pharmaceuticals Industries Ltd. (Nasdaq: T...overwhelming support of the transaction by the Bar...rman and CEO. "We are pleased with the progress th...
(Date:11/21/2008)...ire/ -- In a statewide survey, 33 physicians crede...gery at Presbyterian Hospital of Dallas were honor...f " Super Doctors ." , , Each year, the pub...nal Media, Inc. to survey more than 38,000 medical...If you needed medical care, which doctor would you...
Breaking Medicine News(10 mins):Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2
...hemicals Ltd today said it will acquire the pharma... for 74.5 million dollars. // The company has sig... in CarboGen and Amcis--Solutia Inc's pharmaceutic...man said in a statement. The acquisition includes ...
...ems due to use of drugs in northeastern states, Mi...mar today suggested effective monitoring // and re...s a need to establish effective drug use monitorin...sister states in the northeastern region,Kumar sai...
...nce in the U.S. This shows an increase in 2.5 mil...t//. These individuals between the ages of 19 and...ens with no health insurance and Rite of Passage n... how the new policies will be helpful. They are no...
...l here, who have been abstaining from duty for a w.../ to introduce reservation in higher education ins...ke. The medicos, whose stir has disrupted medical...spital, stepped up their agitation with the hunger...
Other Medicine News:Health News:No Insurance For Young Adults In U.S. 2Health News:No Insurance For Young Adults In U.S. 3
(Date:11/20/2008).... 20 PAREXEL Internation... biopharmaceutical services provider, today announ...provide regulatory consulting and clinical researc...ce, PAREXEL now has locations throughout five impo...which also include Argentina, Brazil, Chile, and M...
(Date:11/19/2008)...ientists report basic findings on critical enzyme,...better treat an array of disorders , , MEMP...ientists at St. Jude Children,s Research Hospital ... the body,s enzyme workhorses called calpains. ,...lpains function in many cellular processes, includ...
(Date:11/18/2008)...christmasseals.org to learn more, make a donation...NGTON, Nov. 17 Millions...th, courtesy of the American Lung Association. The... fundraising tradition dating back to 1907 when th...osis. , , "Most Americans alive today hav...
(Date:11/13/2008)..., Mass., Nov. 13 Hologic...facturer and supplier of premium,diagnostics, medi...d to,serving the healthcare needs of women, today ...k pivotal clinical trial. The Cervista HPV high-ri...e U.S. and is expected to be,launched in the Europ...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4PhoneTree Announces New Patient Messaging Product and Pricing Options 4660 1Roper Industries Announces Record Third Quarter Results 4657 1Roper Industries Announces Record Third Quarter Results 4657 2Roper Industries Announces Record Third Quarter Results 4657 3Roper Industries Announces Record Third Quarter Results 4657 4Roper Industries Announces Record Third Quarter Results 4657 5Roper Industries Announces Record Third Quarter Results 4657 6Roper Industries Announces Record Third Quarter Results 4657 7Roper Industries Announces Record Third Quarter Results 4657 8Roper Industries Announces Record Third Quarter Results 4657 9Roper Industries Announces Record Third Quarter Results 4657 10Male Drivers are Hitting Killing Most Child Pedestrians New Study Shows 4654 1Male Drivers are Hitting Killing Most Child Pedestrians New Study Shows 4654 2Male Drivers are Hitting Killing Most Child Pedestrians New Study Shows 4654 3California Association of Marriage 26 Family Therapists Offers Tips on How to Cope With a Traumatic Event 4651 1California Association of Marriage 26 Family Therapists Offers Tips on How to Cope With a Traumatic Event 4651 2
... at International Conference on Antiviral,Research...- ADVENTRX,Pharmaceuticals, Inc. , a biopharmaceut...ommercializing proprietary product,candidates for ...nnounced today that it presented results demonstra...influenza (bird flu) viruses when,the Company,s br...
...Plus Minocycline Showed Substantial,Reduction of D...Remitting Multiple Sclerosis , Combination Treatme...nd Was Well Tolerated , KANSAS CITY, Mo, May 4, 20...y showed that a combination of Copaxone,(glatirame...c,minocycline reduced T1 Gadolinium (Gd)-enhancing...
Other Medicine Technology:ANX-201 Drug Combination Demonstrates Synergistic Activity Against,Human and Bird Flu Viruses 2ANX-201 Drug Combination Demonstrates Synergistic Activity Against,Human and Bird Flu Viruses 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 6Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 7Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 8Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 9Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 10Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 11Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 12
Needle holder, delicate, curved without lock
Rhoton microscopic forceps, straight
Microscopic scissors, curved
Our unique velcro design apron with elasticized back panels for additional support and comfort. Shoulder pads are a standard. Shoulder drop-away optional.
Medicine Products: